{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:06:52Z","timestamp":1774033612246,"version":"3.50.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["R01DA021525"],"award-info":[{"award-number":["R01DA021525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Institutes of Health Research (CA)","award":["MSH-141971"],"award-info":[{"award-number":["MSH-141971"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["R25-DA037756"],"award-info":[{"award-number":["R25-DA037756"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194162","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T13:31:03Z","timestamp":1522071063000},"page":"e0194162","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs"],"prefix":"10.1371","volume":"13","author":[{"given":"Lianping","family":"Ti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Eugenia","family":"Soc\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-J","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Nosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-2928","authenticated-orcid":true,"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"PK Nelson","year":"2011","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection","volume":"44","author":"M Alter","year":"2006","journal-title":"J. Hepatol."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users","volume":"107","author":"J Bruneau","year":"2012","journal-title":"Addict. Abingdon Engl."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/001789690306200307","article-title":"Hepatitis C and injecting drug use: The realities of stigmatisation and discrimination","volume":"62","author":"S Habib","year":"2003","journal-title":"Health Educ J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0974-777X.52979","article-title":"Association Between Hepatitis C and Hepatocellular Carcinoma","volume":"1","author":"LJ de Oliveria Andrade","year":"2009","journal-title":"J. Glob. Infect. Dis."},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.17.1.19296","article-title":"Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study","volume":"17","author":"K Hayashi","year":"2014","journal-title":"J. Int. AIDS Soc."},{"key":"ref7","article-title":"France to provide universal access to hepatitis C treatment","author":"K Alcorn","year":"2016","journal-title":"AIDS Map"},{"key":"ref8","unstructured":"Australian Government Department of Health. Turnbull govt invests over $1B to cure hep C [Internet]. 2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.health.gov.au\/internet\/ministers\/publishing.nsf\/Content\/FAE2B65331456243CA257F20006D4C48\/$File\/SL-154.pdf\" xlink:type=\"simple\">http:\/\/www.health.gov.au\/internet\/ministers\/publishing.nsf\/Content\/FAE2B65331456243CA257F20006D4C48\/$File\/SL-154.pdf<\/ext-link>"},{"key":"ref9","unstructured":"BC Ministry of Health. More patients to benefit from hepatitis C treatments [Internet]. 2017 [cited 2017 Mar 4]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/news.gov.bc.ca\/releases\/2017HLTH0037-000374\" xlink:type=\"simple\">https:\/\/news.gov.bc.ca\/releases\/2017HLTH0037-000374<\/ext-link>"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2893.2010.01279.x","article-title":"Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents","volume":"18","author":"J Grebely","year":"2011","journal-title":"J. Viral Hepat"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jvh.12129","article-title":"Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999\u20132011","volume":"21","author":"J Iversen","year":"2014","journal-title":"J. Viral Hepat"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"SH Mehta","year":"2008","journal-title":"J. Community Health"},{"issue":"Suppl 2","key":"ref13","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/cit271","article-title":"Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all","volume":"57","author":"P Bruggmann","year":"2013","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.drugpo.2015.07.005","article-title":"Recommendations for the management of hepatitis C virus infection among people who inject drugs","volume":"26","author":"J Grebely","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1360-0443.2003.00670.x","article-title":"Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment","volume":"99","author":"A Palepu","year":"2004","journal-title":"Addict. Abingdon Engl."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","volume":"105","author":"S Uhlmann","year":"2010","journal-title":"Addict. Abingdon Engl."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/add.12970","article-title":"Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids","volume":"110","author":"L Lappalainen","year":"2015","journal-title":"Addict. Abingdon Engl."},{"key":"ref18","first-page":"31A","article-title":"Impact of drug use and opioid substitution therapy on hepatitis C reinfection","volume":"63","author":"N Islam","year":"2016","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.drugpo.2015.04.015","article-title":"An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: structural barriers and public health potential","volume":"26","author":"DC Perlman","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/cid\/civ929","article-title":"Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative","volume":"62","author":"M-J Milloy","year":"2016","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","article-title":"Needle exchange is not enough: lessons from the Vancouver injecting drug use study","volume":"11","author":"SA Strathdee","year":"1997","journal-title":"AIDS Lond. Engl."},{"key":"ref22","article-title":"Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study","volume":"3","author":"E Wood","year":"2006","journal-title":"Harm. Reduct. J."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"J Robins","year":"2000","journal-title":"Epidemiol. Camb. Mass."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"M Hern\u00e1n","year":"2000","journal-title":"Epidemiol. Camb. Mass."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Berg KM, Litwin A, Li X, Heo M, Arnsten JH. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. 2011.","DOI":"10.1016\/j.drugalcdep.2010.07.025"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s10461-013-0584-z","article-title":"Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users","volume":"18","author":"H Reddon","year":"2014","journal-title":"AIDS Behav"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugalcdep.2016.05.018","article-title":"Faster entry into HIV care among HIV-infected drug users who had been in drug-use treatment programs","volume":"165","author":"LI Gardner","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"ref28","unstructured":"HCV Next. The Increasing Role of Methadone Clinics for HCV Treatment, Education. Healio [Internet]. 2017 [cited 2017 Dec 6]; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.healio.com\/infectious-disease\/hepatitis-c\/news\/print\/hcv-next\/%7Bb4df1e0a-547b-4405-ab6a-38836b0915ef%7D\/the-increasing-role-of-methadone-clinics-for-hcv-treatment-education\" xlink:type=\"simple\">https:\/\/www.healio.com\/infectious-disease\/hepatitis-c\/news\/print\/hcv-next\/%7Bb4df1e0a-547b-4405-ab6a-38836b0915ef%7D\/the-increasing-role-of-methadone-clinics-for-hcv-treatment-education<\/ext-link>"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jsat.2012.08.007","article-title":"Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program","volume":"43","author":"MR Stein","year":"2012","journal-title":"J. Subst. Abuse Treat"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1016\/j.japh.2017.03.006","article-title":"Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center","volume":"57","author":"NY Isho","year":"2017","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jsat.2012.07.007","article-title":"Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre","volume":"43","author":"MM Islam","year":"2012","journal-title":"J. Subst. Abuse Treat"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatol. Baltim. Md."},{"key":"ref33","article-title":"Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection","year":"2016"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T09:08:15Z","timestamp":1570957695000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194162"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194162","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,26]]}}}